Latest Breaking News On - Achilles therapeutics - Page 2 : comparemela.com

Achilles reports Q1 2024 Financial Results | Company Announcement

Achilles reports Q1 2024 Financial Results | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United-kingdom
London
City-of
Ben-atwell-natalie
Dylan-wilks
Collins-tim-stamper
Annabel-clark-fergus-witt
Tracy-cheung
Miraj-ali
Sukaina-virji
Leverage-the-company
Manufacturing-development

ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024

ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Achilles-therapeutics
Place-earnings

Supporting female leaders to advance cell and gene therapies

Supporting female leaders to advance cell and gene therapies
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Katy-newton
Jason-jones
Amy-hines
Development-at-achilles-therapeutics
International-women-day
Global-business-development-lead-at-cellular-origins
International-women
Chief-executive-officer
Senior-vice-president
Process-development
Achilles-therapeutics

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & Entera Bio (NASDAQ:ENTX)

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & Entera Bio (NASDAQ:ENTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Israel
London
City-of
United-kingdom
Jerusalem
Israel-general
Amgen-inc
Achilles-therapeutics-plc
Entera-bio-ltd
Achilles-therapeutics
Get-free-report

Achilles Therapeutics (NASDAQ:ACHL) PT Lowered to $6.00

Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […]

United-states
America
Piper-sandler
Fcpm-iii-services
Blackrock-inc
Achilles-therapeutics-plc
Citadel-advisors
Renaissance-technologies
Achilles-therapeutics
Free-report
Chardan-capital
Vestal-point-capital